Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

SIM01 significantly reduced post-COVID symptoms and is safe.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Third booster shots enhance the immune system's response to the COVID-19 virus.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

2021 saw a slow return to normalcy and increased scientific engagement despite COVID-19 challenges.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Long COVID is more common in those with severe initial infections, but not linked to blood group.